RCM
PFE icon

Radnor Capital Management’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.07M Sell
85,497
-200
-0.2% -$4.85K 0.33% 81
2025
Q1
$2.17M Hold
85,697
0.36% 69
2024
Q4
$2.27M Sell
85,697
-17,005
-17% -$451K 0.38% 71
2024
Q3
$2.97M Buy
+102,702
New +$2.97M 0.44% 57
2024
Q2
Sell
-86,007
Closed -$2.39M 263
2024
Q1
$2.39M Sell
86,007
-2,865
-3% -$79.5K 0.41% 56
2023
Q4
$2.56M Buy
88,872
+11,635
+15% +$335K 0.48% 48
2023
Q3
$2.56M Buy
+77,237
New +$2.56M 0.51% 41
2023
Q2
Sell
-58,971
Closed -$2.41M 216
2023
Q1
$2.41M Buy
58,971
+9,054
+18% +$369K 0.63% 33
2022
Q4
$2.65M Buy
49,917
+1,817
+4% +$96.4K 0.65% 32
2022
Q3
$2.11M Sell
48,100
-1,700
-3% -$74.4K 0.61% 37
2022
Q2
$2.61M Buy
49,800
+3,800
+8% +$199K 0.71% 29
2022
Q1
$2.38M Sell
46,000
-368
-0.8% -$19K 0.6% 43
2021
Q4
$2.74M Buy
+46,368
New +$2.74M 0.68% 33
2021
Q3
Sell
-51,298
Closed -$2.01M 179
2021
Q2
$2.01M Hold
51,298
0.68% 34
2021
Q1
$1.86M Hold
51,298
0.6% 45
2020
Q4
$1.89M Hold
51,298
0.53% 41
2020
Q3
$1.88M Buy
51,298
+4,498
+10% +$165K 0.63% 37
2020
Q2
$1.58M Buy
46,800
+2,500
+6% +$84.3K 0.57% 39
2020
Q1
$1.45M Sell
44,300
-5,481
-11% -$179K 0.59% 39
2019
Q4
$1.95M Sell
49,781
-2,300
-4% -$90.1K 0.6% 37
2019
Q3
$1.87M Buy
52,081
+800
+2% +$28.7K 0.61% 38
2019
Q2
$2.22M Sell
51,281
-2,827
-5% -$122K 0.73% 28
2019
Q1
$2.3M Buy
54,108
+1,200
+2% +$51K 0.75% 28
2018
Q4
$2.31M Buy
52,908
+129
+0.2% +$5.63K 0.83% 22
2018
Q3
$2.33M Buy
52,779
+410
+0.8% +$18.1K 0.74% 29
2018
Q2
$1.9M Buy
52,369
+200
+0.4% +$7.26K 0.7% 36
2018
Q1
$1.85M Sell
52,169
-508
-1% -$18K 0.63% 39
2017
Q4
$1.91M Buy
52,677
+1,300
+3% +$47.1K 0.61% 40
2017
Q3
$1.73M Hold
51,377
0.58% 39
2017
Q2
$1.73M Hold
51,377
0.58% 39
2017
Q1
$1.76M Sell
51,377
-2,299
-4% -$78.7K 0.59% 38
2016
Q4
$1.74M Buy
+53,676
New +$1.74M 0.6% 38